Contraceptive efficacy and tolerability of ethinylestradiol 20 µg/drospirenone 3 mg in a flexible extended regimen: an open-label, multicentre, randomised, controlled study

BACKGROUND: The contraceptive efficacy and tolerability of a new flexible extended regimen of ethinylestradiol (EE) 20 μg/drospirenone (DRSP) 3 mg to extend the menstrual cycle and enable management of intracyclic (breakthrough) bleeding (flexible(MIB)) was investigated and the bleeding pattern comp...

Descripción completa

Detalles Bibliográficos
Autores principales: Klipping, Christine, Duijkers, Ingrid, Fortier, Michel P, Marr, Joachim, Trummer, Dietmar, Elliesen, Jörg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Group 2012
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3353880/
https://www.ncbi.nlm.nih.gov/pubmed/22454003
http://dx.doi.org/10.1136/jfprhc-2011-100213

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3353880/
https://www.ncbi.nlm.nih.gov/pubmed/22454003
http://dx.doi.org/10.1136/jfprhc-2011-100213

Ejemplares similares